文献
J-GLOBAL ID:201702220527231295
整理番号:17A1165406
CpGアイランドメチル化表現型はマイクロサテライト安定BRAF変異結腸直腸癌の高リスク患者を同定する【Powered by NICT】
CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers
著者 (39件):
Vedeld Hege Marie
(Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital - Norwegian Radium Hospital, Oslo, Norway)
,
Vedeld Hege Marie
(K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway)
,
Vedeld Hege Marie
(Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway)
,
Merok Marianne
(Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital - Norwegian Radium Hospital, Oslo, Norway)
,
Merok Marianne
(Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway)
,
Merok Marianne
(Department of Gastrointestinal Surgery, Oslo University Hospital - Aker, Oslo, Norway)
,
Jeanmougin Marine
(Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital - Norwegian Radium Hospital, Oslo, Norway)
,
Jeanmougin Marine
(K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway)
,
Jeanmougin Marine
(Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway)
,
Danielsen Stine A.
(Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital - Norwegian Radium Hospital, Oslo, Norway)
,
Danielsen Stine A.
(K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway)
,
Danielsen Stine A.
(Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway)
,
Honne Hilde
(Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital - Norwegian Radium Hospital, Oslo, Norway)
,
Honne Hilde
(K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway)
,
Honne Hilde
(Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway)
,
Presthus Gro Kummeneje
(Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital - Norwegian Radium Hospital, Oslo, Norway)
,
Presthus Gro Kummeneje
(Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway)
,
Presthus Gro Kummeneje
(Department of Biosciences, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway)
,
Svindland Aud
(Department of Pathology, Oslo University Hospital, Oslo, Norway)
,
Svindland Aud
(Faculty of Medicine, University of Oslo, Oslo, Norway)
,
Sjo Ole H.
(K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway)
,
Sjo Ole H.
(Department of Gastrointestinal Surgery, Oslo University Hospital - Aker, Oslo, Norway)
,
Hektoen Merete
(Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital - Norwegian Radium Hospital, Oslo, Norway)
,
Hektoen Merete
(K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway)
,
Hektoen Merete
(Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway)
,
Eknaes Mette
(Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital - Norwegian Radium Hospital, Oslo, Norway)
,
Eknaes Mette
(K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway)
,
Eknaes Mette
(Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway)
,
Nesbakken Arild
(K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway)
,
Nesbakken Arild
(Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway)
,
Nesbakken Arild
(Department of Gastrointestinal Surgery, Oslo University Hospital - Aker, Oslo, Norway)
,
Lothe Ragnhild A.
(Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital - Norwegian Radium Hospital, Oslo, Norway)
,
Lothe Ragnhild A.
(K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway)
,
Lothe Ragnhild A.
(Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway)
,
Lothe Ragnhild A.
(Department of Biosciences, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway)
,
Lind Guro E.
(Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital - Norwegian Radium Hospital, Oslo, Norway)
,
Lind Guro E.
(K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway)
,
Lind Guro E.
(Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway)
,
Lind Guro E.
(Department of Biosciences, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway)
資料名:
International Journal of Cancer
(International Journal of Cancer)
巻:
141
号:
5
ページ:
967-976
発行年:
2017年
JST資料番号:
A0267B
ISSN:
0020-7136
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)